FYERS
Home
/
Stocks
/
Profit Loss
/
Eiko Lifesciences Profit & Loss

Eiko Lifesciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹11 Cr₹7 Cr₹8 Cr₹11 Cr₹84 L₹56 L₹62 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹41 L₹13 L₹32 L₹26 L₹27 L₹23 L₹9 L₹13 L₹26 L₹1 L₹5 L-₹4 L₹1 L₹5 L₹3 L₹3 L₹0₹2 L₹1 L
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹12 Cr₹8 Cr₹8 Cr₹11 Cr₹85 L₹61 L₹58 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹15 Cr₹16 Cr₹10 Cr₹10 Cr₹9 Cr₹10 Cr₹7 Cr₹8 Cr₹11 Cr₹93 L₹46 L₹2 Cr₹5 Cr₹6 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹73 L₹55 L₹66 L-₹4 L₹18 L-₹96 L-₹1 Cr-₹2 Cr-₹39 L-₹33 L-₹12 L-₹15 L-₹9 L
₹13 L₹12 L₹7 L₹10 L₹5 L₹7 L₹3 L₹4 L₹3 L₹10 L₹70,000₹3 L₹8 L₹6 L₹7 L₹15 L₹2 L₹5 L₹4 L
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹54 L₹35 L₹46 L-₹18 L₹14 L-₹1 Cr-₹1 Cr-₹2 Cr-₹50 L-₹60 L-₹18 L-₹24 L-₹18 L
₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹40 L₹26 L₹35 L-₹13 L₹10 L-₹74 L-₹1 Cr-₹1 Cr-₹37 L-₹45 L-₹14 L-₹17 L-₹13 L

Share Price Live Stats

Open (₹)45.66
Volume (₹)27,216.00
High (₹)46.35
Upper Circuit55.08
Low (₹)44.80
Lower Circuit36.72
Prev Close45.90
52W High (₹)64.44
Price45.76
52W Low (₹)44.75

Share Market Cap & Key Ratios Overview

M.Cap (₹)67.25 Cr
Div. Yield (%)0.00
PE Ratio13.21
Debt to Equity0.05
Price to Book1.27
Book Value41.26
EPS (TTM)3.47
Face Value10.00
ROE (%)7.76

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDS-ANSE
PIDILITIND-ANSE
SRF-ANSE
FLUOROCHEM-ANSE
NAVINFLUOR-ANSE
GODREJIND-ANSE
DEEPAKNTR-ANSE
AETHER-ANSE
ATUL-ANSE
AARTIIND-ANSE
EIKO-XNSE
LTP
1W Low
1W High
Market cap (₹)
22307.5+403.5 (1.84%)
21477.75
22617.10
2,02,607Cr
1567.45-17.55 (-1.11%)
1538.45
1629
1,59,705Cr
2483-54.1 (-2.13%)
2460.60
2557.65
74,335Cr
4768.15+239.85 (5.30%)
4475
4884
52,827Cr
8555.55-51.6 (-0.60%)
8503.85
8949
44,626Cr
1127.25-32.25 (-2.78%)
1101.75
1183.55
37,835Cr
1587.1-53.75 (-3.28%)
1583.80
1722.15
22,449Cr
1681+62.2 (3.84%)
1589.70
1691.40
21,803Cr
6250-59.15 (-0.94%)
6171.15
6395.40
18,682Cr
493+1.95 (0.40%)
485.80
511.70
18,298Cr
45.76+0.25 (0.55%)
44.80
48.29
67Cr

Key Highlights of Eiko Lifesciences Ltd’s P&L

In 2025-03-31, Eiko Lifesciences Ltd reported total revenue of ₹38.38Cr, compared with ₹10.41Cr in 2020-03-31, reflecting Eiko Lifesciences Ltd turnover.

Depreciation was ₹73.72Lakh and finance costs were ₹16.52Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹3.06Cr in 2025-03-31 as compared to ₹-₹4.93Cr in 2020-03-31.

Net Profit (PAT) was ₹2.11Cr in 2025-03-31 compared with ₹-₹1.91Cr in 2020-03-31.

Earnings per share (EPS) were ₹1.53 in 2025-03-31, compared with ₹-4.99 in 2020-03-31.